The story of Viagra, and its developer copyright, presents a challenging case study for investors. Originally a blockbuster drug, yielding billions in revenue , its exclusivity period created a deluge of generic https://one-bookmark.com/story21352006/sildenafil-and-big-pharma-a-risky-investment